Experience with nutritional support using percutaneous endoscopic gastrostomy in children with solid tumors (Experience of the Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev)

Children with malignancies have a high risk of developing inanition for a variety of reasons associated with both a tumor and the toxicity of performed therapy. Enteral feeding via percutaneous endoscopic gastrostomy (PEG) is one of the procedures to correction the nutritional status. The authors show the feasibility and safety of PEG in children with solid malignancies, as well as the possibility of using PEG in patients receiving the cycles of intensive chemoradiation therapy. The paper analyzes the case histories of patients undergoing PEG to correct the nutritional status, as well as indications for its application, complications, and efficiency of this technique. Furthermore, a procedure for gastrostoma application and the specific features of management in patients with PEG are described in detail.

1. Gatta G., Botta L., Rossi S. et al; EUROCARE Working Group. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15(1):35–47.

2. Donaldson S. S., Wesley M. N., DeWys W. D. et al. A study of the nutritional status of pediatric cancer patients. Am J Dis Child 1981;135(12):1107–12.

3. Rickard K. A., Detamore C. M., Coates T. D. et al. Effect of nutrition staging on treatment delays and outcome in Stage IV neuroblastoma. Cancer 1983;52:587–98.

4. Consensus statement. Nutritional morbidity in children with cancer. Int J Cancer Suppl 1998;11:92.

5. Sala A., Pencharz P., Barr R. D. Children, cancer, and nutrition – A dynamic triangle in review. Cancer 2004;100(4):677–87.

6. Holmes S. Enteral feeding and percutaneous endoscopic gastrostomy. Nurs Stand 2004;18:41–3.

7. Ponsky J. L., Gauderer M. W. Percutaneous endoscopic gastrostomy: indications, limitations, techniques, and results. World J Surg 1989;13(2):165–70.

8. Gaudener M. W. L. Percutaneous endoscopic gastrostomy: a 10‑year experience with 220 children. J Pediatr Surg 1991;26:288–94.

9. Aquino V. M., Smyrl C. B., Hagg R. et al. Enteral nutritional support by gastrostomy tube in children with cancer. J Pediatr 1995;127:58–62.

10. Buderus S., Sonderkötter H., Fleischhack G., Lentze M. J. Diagnostic and therapeutic endoscopy in children and adolescents with cancer. Pediatr Hematol Oncol 2012;29(5):450–60.

11. Nitenberg G., Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 2000;34(3):137–68.

12. Ward E., Hopkins M., Arbuckle L. et al. Nutritional problems in children treated for medulloblastoma: Implications for enteral nutrition support. Pediatric Blood Cancer 2009;53(4):570–5.

13. Royal College of Nursing(2010). Nutrition in children and young people with cancer. London: RCN. Assess: http://www.rcn.org.uk / __data / assets / pdf_file / 0010 / 338689 / 003805. pdf(07.08.2014)

14. Carter P., Carr D., van Eys J., Coody D. Nutritional parameters in children with cancer. J Am Diet Assoc 1983;82:616.

15. Reilly J. J., Weir J., McColl J. H., Gibson B. E. Prevalence of protein energy malnutrition at diagnosis in children with acute lymphoblastic leukemia. J Pediatr Gastroenterol Nutr 1999;29:194–7.

16. Mejia-Arangure J. M., Fajardo-Gutierrez A., Bernaldez-Rios R. et al. Nutrition state alterations in children with /ALL during induction and consolidation of chemotherapy. Arch Med Res 1997;28:273–9.

17. Tenardi R. D., Frühwald M. C., Jürgens H. et al. Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy. Pediatr Blood Cancer 2012;59(4):621–6.

18. Juergens C., Weston C., Lewis I. et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E. W. I. N. G. 99 clinical trial. Pediatr Blood Cancer 2006;47(1):22–9.

19. Schmitt F., Caldari D., Corradini N. et al Tolerance and efficacy of preventive gastrostomy feeding in pediatric oncology. Pediatr Blood Cancer 2012;59(5):874–80.

20. Pennington C. To PEG or not to PEG. Clin Med 2002;2:250–5.

21. Loser C., Asch G., Hebuterne X. et al. ESPEN guidelines on artificial enteral nutrition-percutaneous endoscopic gastrostomy(PEG). Clin Nutr 2005;24:848–61.

22. Wilson L., Oliva-Hemker M. Percutaneous endoscopic gastrostomy in small medically complex infants. Endoscopy 2001;33:433–6.

23. Skolin I., Hernell O., Larsson M. V. et al. Endoscopic percutaneous gastrostomy in children with malignant disease. J Pediatr Oncol Nurs 2002;19:154–63.

24. Parbhoo D. M., Tiedemann K., Catto-Smith A. G. Clinical outcome after percutaneous endoscopic gastrostomy in children with malignancies. Pediatr Blood Cancer 2011;56(7):1146–8.